Search

Your search keyword '"Zalunardo, B"' showing total 116 results

Search Constraints

Start Over You searched for: Author "Zalunardo, B" Remove constraint Author: "Zalunardo, B"
116 results on '"Zalunardo, B"'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models

3. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

4. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

5. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

6. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

7. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

8. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

9. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

10. Timing and characteristics of venous thromboembolism after noncancer surgery

11. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

12. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

13. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

15. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

16. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

17. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

18. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

19. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

20. DVT Management and Outcome Trends, 2001 to 2014

21. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

22. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism

23. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

24. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

25. D-dimer and reduced dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study

26. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

27. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

28. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

29. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

30. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

31. Timing and characteristics of venous thromboembolism after noncancer surgery

32. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

33. A Prognostic Score to Identify Low-risk Outpatients with Acute Deep Vein Thrombosis in the Lower Limbs

34. Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry

35. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism

36. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

37. Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registry

38. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

39. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

40. Mortality after pulmonary embolism in patients with diabetes. Findings from the RIETE registry

41. Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy

43. Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism

44. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

45. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

46. Outcomes in Neurosurgical Patients Who Develop Venous Thromboembolism

47. D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer

48. Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?

49. Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism

50. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

Catalog

Books, media, physical & digital resources